Devro plc (LON:DVO)‘s stock had its “hold” rating reaffirmed by equities researchers at Shore Capital in a research report issued to clients and investors on Thursday.

Other equities analysts have also issued research reports about the stock. Peel Hunt restated a “hold” rating and set a GBX 205 ($2.70) target price on shares of Devro plc in a report on Wednesday, August 2nd. Numis Securities Ltd lifted their target price on shares of Devro plc from GBX 209 ($2.75) to GBX 220 ($2.89) and gave the company a “hold” rating in a report on Thursday, August 3rd. Six equities research analysts have rated the stock with a hold rating, The company currently has a consensus rating of “Hold” and a consensus target price of GBX 202 ($2.66).

Shares of Devro plc (LON DVO) traded down GBX 2.86 ($0.04) during midday trading on Thursday, hitting GBX 230.39 ($3.03). 68,154 shares of the stock traded hands, compared to its average volume of 85,106. Devro plc has a one year low of GBX 139.34 ($1.83) and a one year high of GBX 247 ($3.25).

ILLEGAL ACTIVITY WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at

Devro plc Company Profile

Devro plc is a United Kingdom-based manufacturer of collagen products for the food industry. The Company conducts its operations through three segments: Americas, Asia-Pacific and Europe. The Americas segment includes the Company’s operations in North America and Latin America. The Asia-Pacific segment includes the Company’s operations in Australia, New Zealand, Japan, China and the rest of South East Asia.

Analyst Recommendations for Devro plc (LON:DVO)

Receive News & Ratings for Devro plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Devro plc and related companies with Analyst Ratings Network's FREE daily email newsletter.